Expanded Access Protocol of Givosiran for Patients With Acute Hepatic Porphyria

Anagrelide vs. Hydroxyurea - Efficacy and Tolerability Study in Patients With Essential Thrombocythaemia

NCT01065038 ·Status: COMPLETED ·Phase: PHASE3

Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance

NCT04285086 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Safety and Efficacy of Asfotase Alfa in Patients With Hypophosphatasia (HPP)

NCT02456038 ·Status: COMPLETED ·Phase: PHASE2

A Study Evaluating the Efficacy and Safety of AG-348 in Regularly Transfused Adult Participants With Pyruvate Kinase Deficiency (PKD)

NCT03559699 ·Status: COMPLETED ·Phase: PHASE3

A Study of Once Monthly Intravenous or Subcutaneous Mircera in Participants With Chronic Kidney Disease on Hemodialysis.

NCT00717821 ·Status: COMPLETED ·Phase: PHASE3

A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin

NCT01473420 ·Status: COMPLETED ·Phase: PHASE3

Evaluating Aranesp® in Subjects With End Stage Renal Disease onChronic Hemodialysis

NCT00117104 ·Status: COMPLETED ·Phase: PHASE4

A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia

NCT00048035 ·Status: COMPLETED ·Phase: PHASE2

A Non-Interventional Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Patients With Chronic Kidney Disease Not on Dialysis

NCT01892202 ·Status: NO_LONGER_AVAILABLE

A Phase 3 Study Comparing the Effects of Intravenous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin

NCT01473407 ·Status: COMPLETED ·Phase: PHASE3

A Study of Subcutaneous C.E.R.A. for the Maintenance of Hemoglobin Levels in Participants With Chronic Renal Anemia Not on Dialysis.

NCT00642304 ·Status: COMPLETED ·Phase: PHASE3

A Study to Access Efficacy and Safety of P1101 in Chinese PV Patients Who Are Intolerant or Resistance to HU

NCT05485948 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

NCT07266155 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients

NCT00701714 ·Status: TERMINATED ·Phase: PHASE3

An Open-Label Study to Evaluate the Effect of Every Other Week PROCRIT� (Epoetin Alfa) Dosing (40,000-60,000 Units) On Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients (CHAMPS II)

NCT00317902 ·Status: COMPLETED ·Phase: PHASE4

A Study for Monthly Methoxy Polyethylene Glycol-Epoetin Beta Treatment in Patients With Chronic Renal Anaemia

NCT01066000 ·Status: TERMINATED ·Phase: PHASE4

A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA Naïve

NCT03682536 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Safety and Efficacy Study for Epoetin Alfa in Pre-dialysis Subjects.

NCT00364260 ·Status: COMPLETED ·Phase: PHASE3

A Study of Subcutaneous C.E.R.A. for the Treatment of Anemia in Pre-Dialysis Patients.

NCT00576628 ·Status: COMPLETED ·Phase: PHASE3

An Observational Study of Mircera (Methoxy Polyethylene Glycol-epoetin Beta) in Anemic Patients With Chronic Kidney Disease (NORM)

NCT01417377 ·Status: COMPLETED

A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients

NCT00081484 ·Status: COMPLETED ·Phase: PHASE3

A Study of Mircera for the Maintenance Treatment of Participants With Chronic Renal Anemia

NCT00550680 ·Status: COMPLETED ·Phase: PHASE3

An Observational Study of Mircera (Methoxy Polyethylene Glycol-epoetin Beta) in Patients With Chronic Kidney Disease Not On Dialysis

NCT01318512 ·Status: COMPLETED

A Study of Intravenous Mircera (C.E.R.A or Methoxy Polyethylene Glycol-epoetin Beta) for the Maintenance Treatment of Hemodialysis Participants With Chronic Renal Anemia

NCT00605293 ·Status: COMPLETED ·Phase: PHASE3

A Study of Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia

NCT00661505 ·Status: COMPLETED ·Phase: PHASE3